Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy
Clinical trial NCT03821454 · UNKNOWN
Trial details
- NCT number
- NCT03821454
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2020-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.